Penserra Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Penserra Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19,600	Closed	-$757K	–	1121
2024 Q3	$757K	Buy	+19,600	New	+$699K	0.02%	470
2021 Q4	–	Sell	-815	Closed	-$16K	–	1401
2021 Q3	$16K	Buy	815 +15	+2%	+$324	﹤0.01%	1282
2021 Q2	$18K	Buy	800 +15	+2%	+$347	﹤0.01%	1170
2021 Q1	$18K	Sell	785 -10	-1%	-$238	﹤0.01%	979
2020 Q4	$15K	Buy	795 +499	+169%	+$9.74K	﹤0.01%	883
2020 Q3	$6K	Buy	+296	New	+$5.34K	﹤0.01%	854

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Penserra Capital Management's COLL Position: Q4 2024 in Review

Penserra Capital Management sold out of Collegium Pharmaceutical (COLL) in Q4 2024, closing a stake of 19,600 shares — an estimated $757K sold.

Penserra Capital Management first reported a position in COLL in Q3 2020 and held it in 6 quarters. The position peaked at $757K in Q3 2024. 238 funds tracked by Wall St. Rank hold COLL as of Q4 2024.

Penserra Capital Management reported no remaining Collegium Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Penserra Capital Management sold 19,600 Collegium Pharmaceutical shares in Q4 2024, an estimated $757K.
Penserra Capital Management first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 6 quarters.
Penserra Capital Management's Collegium Pharmaceutical position peaked at $757K in Q3 2024.
238 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2024.

Based on Penserra Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.